Categories

Learn more

Contact us for more information

Contact us

SWM International Completes Acquisition of Scapa Group Plc

15 Apr, 2021

Schweitzer-Mauduit International, Inc. (“SWM” or the “Company”) (NYSE: SWM), announced today that it has finalized its acquisition of Scapa Group Plc, a UK-based innovation, design, and manufacturing solutions provider for healthcare and industrial markets. The newly combined company’s annualized sales are approaching $1.5 billion.

Scapa Healthcare Boosts Manufacturing Capabilities at its Hydrocolloid Technology Center in Orangeburg, New York

6 Apr, 2021

Scapa Healthcare, the trusted strategic partner of choice for the world’s leading companies in advanced wound care, consumer wellness and medical device & fixation, today announced new enhancements at its Hydrocolloid Technology Center in Orangeburg, New York. The company continues to make significant investments to meet growing customer demands for premium medical-grade hydrocolloid adhesive technologies globally. This includes new automated and visual systems for ostomy and consumer products as well as enhancements to high-speed finished packaging, R&D capabilities, unique device identifier (UDI) systems for medical devices, and forecasting & supply chain management tools.

Scapa Healthcare Expands Topical Skin Care Capabilities at its Dallas, TX Technology Center

9 Mar, 2021

Scapa Healthcare, the trusted strategic partner of choice for the world’s leading companies in advanced wound care, consumer wellness and medical device & fixation, announced today the expansion and enhancement of its Technology Center in Dallas, TX. The company has undertaken significant investment in its topical skin care capabilities to meet increasing customer demands for medicated topical and cosmetic products.

Scapa Healthcare Enhances Manufacturing and Innovation Capabilities at its Knoxville, TN Center of Excellence

9 Feb, 2021

Scapa Healthcare announced the enhancement of its manufacturing and research & development capabilities at its Knoxville, TN center of excellence (COE). The company’s multimillion dollar investments at this facility have created four innovation and product development labs to provide a collaborative space for the development of new technologies and products; contract design and manufacturing operations for over-the-counter (OTC) drugs and pharmaceuticals; and the installation of high speed automated vision systems that enhance process controls to ensure quality and consistency.

Scapa Healthcare Expands Medical-Grade Adhesive Coating Capabilities Globally

13 Jan, 2021

Scapa Healthcare, the trusted strategic partner of choice for the world’s leading companies in advanced wound care, consumer wellness and medical device & fixation, today announced expanded medical-grade adhesive coating capabilities in its Windsor, CT and Gargrave, UK facilities. The newly added coating lines increase Scapa’s capacity to custom design and produce polyurethane and polyvinyl chloride foams coated with silicone gels, water-based and solvent-based acrylic adhesives.

Scapa Healthcare Introduces a Second-Generation Hydrocolloid Adhesive

21 Mar, 2019

The technology also offers high absorption properties which make it ideal for ostomy, wound care and consumer applications where the adhesive comes in contact with fluids. The technology is suitable for users with sensitive skin as the formulation is made of non-animal derived ingredients, colophony and is latex-free.